Coronavirus disease 2019 (COVID-19) is of zoonotic origin and caused by the novel beta coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Rapid diagnosis of SARS-CoV-2 infection will help healthcare professionals to treat patients and control the disease more efficiently and effectively.
The product is a rapid, lateral flow immumoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigen form anterior nasal swabs that are self-collected by an aindividual aged 18 years or older or are collected by an adult from an individual younger than 18 years old. This test is intended for use in individuals with symptoms or other epidemiological reasons to suspect a COVID-19 infection.
||SARS-CoV-2 Antigen Rapid Test for Self Testing